PATENT CLAIM ANALYSIS

Application Number: 16140120
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "654000"]

Abstract:
A method of treating symptoms of a subtype of epilepsy, e.g., Dravet syndrome, in a patient diagnosed with a subtype of epilepsy, by administering to the patient an effective dose of a fenfluramine formulation in combination with a ketogenic diet over a period of time sufficient to reduce or completely eliminate seizures in the patient. Also provided are compositions and kits finding use in practicing embodiments of the methods.

Claim (Index 13):
The liquid fenfluramine formulation according to  claim 12 , wherein the thickening agent is selected from the group consisting of hydroxyethylcellulose, xanthan gum, povidone, hydroxypropylcellulose, hydroxyproylmethylcellulose, copovidone, acacia gum, guar gum, locust bean gum, polyethylene oxide and combinations thereof.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 97.0
- Lexical Diversity: 1.53061
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16090039', '14881969', '14447253', '15771379', '15449402']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7427378910362995
- 35 USC 102 Novelty (BERT): 0.5171825686806769
- Combined Prediction Score: 0.7201823588007372
- Mean Citation Score: 270.84679
- Max Citation Score: 286.414
- Similarity Product: 178.5231311318874

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test